Pfizer Plans to Seek Booster Approval for 16- and 17-Year-Olds
Nov. 30, 2021 — Pfizer and BioNTech plan to apply for FDA authorization this week for a booster COVID-19 vaccine for 16- and 17-year-olds. “We expect to share updates on this soon,” Kit Longley, a Pfizer spokesman, told The Washington Post. The FDA could authorize the extra dose within a week. If approved, the additional … Read more